Bruker (BRKR) Other financing activities (2010 - 2026)

Bruker (BRKR) has reported Other financing activities for 12 consecutive years, with -$5.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 614.29% year-over-year to -$5.0 million; the trailing twelve-month figure through Jun 2026 stood at -$3.2 million (up 88.57% YoY), and the FY2025 full-year result was -$8.3 million, up 66.67% from the prior year.
• Other financing activities advanced to -$5.0 million in Q1 2026 per BRKR's latest filing, from -$9.4 million in the prior quarter.
• Across five years, Other financing activities topped out at $11.2 million in Q3 2025 and bottomed at -$17.0 million in Q4 2024.
• Historically, Other financing activities has averaged -$3.1 million across 5 years, with a median of -$2.4 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Other financing activities jumped 1344.44% in 2025, then slumped 614.29% in 2026.
• Over 5 years, Other financing activities stood at -$1.2 million in 2022, then slumped by 166.67% to -$3.2 million in 2023, then plunged by 431.25% to -$17.0 million in 2024, then surged by 44.71% to -$9.4 million in 2025, then surged by 46.81% to -$5.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$5.0 million, -$9.4 million, and $11.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.